U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584161) titled 'MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer' on Sept. 24, 2025.
Brief Summary: This is an investigator-initiated, prospective, national multi-center, phase III, randomized, open-label, non-inferiority clinical study. The hypothesis is that using online adaptive radiotherapy technology for moderately fractionated radiotherapy in post-operative patients with cervical/endometrial cancer may reduce radiotherapy-related toxicity and improve quality of life while ensuring target coverage. The objective is to evaluate treatment-related toxicity and efficacy of moderately fractionated online adaptive radiotherapy compared ...